| Primary |
| Drug Use For Unknown Indication |
45.8% |
| Psoriasis |
31.4% |
| Hypertension |
5.1% |
| Diabetes Mellitus |
1.6% |
| Graft Versus Host Disease |
1.6% |
| Cardiovascular Disorder |
1.4% |
| Hyperlipidaemia |
1.4% |
| Prophylaxis |
1.4% |
| Contraception |
1.3% |
| Psoriatic Arthropathy |
1.3% |
| Depression |
1.1% |
| Hypothyroidism |
0.9% |
| Venous Stasis |
0.9% |
| Hypercholesterolaemia |
0.8% |
| Insomnia |
0.8% |
| Irritable Bowel Syndrome |
0.8% |
| Medical Diet |
0.8% |
| Thrombosis Prophylaxis |
0.6% |
| Folliculitis |
0.5% |
| Hypertriglyceridaemia |
0.5% |
|
| Death |
11.0% |
| Pneumonia |
8.8% |
| Pulmonary Embolism |
8.8% |
| Progressive Multifocal Leukoencephalopathy |
6.6% |
| Vomiting |
6.6% |
| Lupus-like Syndrome |
5.5% |
| Lymphadenopathy |
5.5% |
| Muscular Weakness |
5.5% |
| Visual Impairment |
5.5% |
| Pyrexia |
4.4% |
| Appendicitis |
3.3% |
| Endometrial Cancer |
3.3% |
| Hypergammaglobulinaemia Benign Monoclonal |
3.3% |
| Pseudolymphoma |
3.3% |
| Pulmonary Oedema |
3.3% |
| Rash |
3.3% |
| Respiratory Failure |
3.3% |
| Vitamin B12 Deficiency |
3.3% |
| Weight Decreased |
3.3% |
| Cardiac Failure Congestive |
2.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
51.9% |
| Psoriasis |
18.2% |
| Product Used For Unknown Indication |
4.8% |
| Hypertension |
4.4% |
| Diabetes Mellitus |
3.2% |
| Graft Versus Host Disease |
2.6% |
| Prophylaxis |
2.0% |
| Thrombosis Prophylaxis |
2.0% |
| Psoriatic Arthropathy |
1.6% |
| Hypercholesterolaemia |
1.2% |
| Immunosuppression |
1.2% |
| Pustular Psoriasis |
1.2% |
| Angina Pectoris |
1.0% |
| Hypertriglyceridaemia |
1.0% |
| Pityriasis Rubra Pilaris |
0.8% |
| Depression |
0.6% |
| Disseminated Cryptococcosis |
0.6% |
| Folliculitis |
0.6% |
| Hyperlipidaemia |
0.6% |
| Medical Diet |
0.6% |
|
| Pneumonia |
15.4% |
| Completed Suicide |
11.5% |
| Pulmonary Oedema |
9.6% |
| Respiratory Failure |
9.6% |
| Pyrexia |
7.7% |
| Pulmonary Embolism |
5.8% |
| Rash |
5.8% |
| Vomiting |
5.8% |
| Erythema Nodosum |
3.8% |
| Sepsis |
3.8% |
| Weight Decreased |
3.8% |
| Bladder Cancer |
1.9% |
| Clostridium Difficile Colitis |
1.9% |
| Drug Ineffective |
1.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
1.9% |
| Ewing's Sarcoma |
1.9% |
| Guttate Psoriasis |
1.9% |
| Hepatocellular Injury |
1.9% |
| Liver Disorder |
1.9% |
| Lung Neoplasm Malignant |
1.9% |
|
| Concomitant |
| Psoriasis |
43.3% |
| Product Used For Unknown Indication |
29.4% |
| Psoriatic Arthropathy |
11.9% |
| Hypertension |
9.0% |
| Back Pain |
3.0% |
| Drug Use For Unknown Indication |
1.0% |
| Depression |
0.5% |
| Diabetes Mellitus |
0.5% |
| Mineral Supplementation |
0.5% |
| Pyoderma |
0.5% |
| Skin Infection |
0.5% |
|
| Erythrodermic Psoriasis |
11.1% |
| Lymphoma |
11.1% |
| Psoriasis |
11.1% |
| Drug Ineffective |
8.3% |
| Dyslipidaemia |
5.6% |
| Fatigue |
5.6% |
| Hodgkin's Disease Nodular Sclerosis Stage Iv |
5.6% |
| Lymphocyte Morphology Abnormal |
5.6% |
| Rash |
5.6% |
| Breast Cancer |
2.8% |
| Breast Cancer In Situ |
2.8% |
| Convulsion |
2.8% |
| Cutaneous Sarcoidosis |
2.8% |
| Herpes Zoster |
2.8% |
| Lymphoproliferative Disorder |
2.8% |
| Mental Disorder |
2.8% |
| Nephrolithiasis |
2.8% |
| Parkinson's Disease |
2.8% |
| Pneumonia |
2.8% |
| Psoriatic Arthropathy |
2.8% |
|
